© Rosalind Scientific LLC 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.
Home > LY3502970
<< Back to November
oral non-peptide GLP-1R GPCR partial agonist
in Ph. I for Type 2 diabetes, HV study complete
from cell-based screen and opt.
PNAS, Nov. 11, 2020
Chugai, Shizuoka, JP / Eli Lilly, Indianapolis, IN
Chugai/Lilly clinical oral non-peptide GLP-1R GPCR partial agonist
Unlock this content with a Premium membership to read it now.